Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia

Clinical Therapeutics

Volumn 37, Issue 7, 2015, Pages 1443-1453.e2

  Moise, Pamela A ^a   Sakoulas, George ^b   McKinnell, James A ^c,d   Lamp, Kenneth C ^a   Depestel, Daryl D ^a   Yoon, Min J ^a   Reyes, Katherine ^e,f   Zervos, Marcus J ^e,f  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Henry Ford Health System Division of Infectious Diseases   (United States)

^f WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

daptomycin; enterococcus; MIC, enterococci; VRE bacteremia; lactam

Indexed keywords

AMINOTRANSFERASE; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFEPIME; CEFPROZIL; CEFTAROLINE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CREATINE KINASE; DAPTOMYCIN; GENTAMICIN; LINEZOLID; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; ANTIINFECTIVE AGENT; VANCOMYCIN;

AGED; ALLERGY; AMINOTRANSFERASE BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BONE MARROW TRANSPLANTATION; CLINICAL EVALUATION; COMORBIDITY; CRITICAL ILLNESS; DIALYSIS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; FEVER; GASTROINTESTINAL DISEASE; HUMAN; INTENSIVE CARE UNIT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NEUTROPENIA; ORGAN TRANSPLANTATION; RASH; RETROSPECTIVE STUDY; SEPSIS; SIDE EFFECT; SOLID; STATISTICAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; UNITED STATES; VANCOMYCIN RESISTANT ENTEROCOCCUS; ADULT; ANTIBIOTIC RESISTANCE; ENTEROCOCCUS; MICROBIAL SENSITIVITY TEST; MIDDLE AGED; RETREATMENT; YOUNG ADULT;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; DAPTOMYCIN; ENTEROCOCCUS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETREATMENT; RETROSPECTIVE STUDIES; UNITED STATES; VANCOMYCIN; VANCOMYCIN RESISTANCE; YOUNG ADULT;

EID: 84937633497     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2015.04.008     Document Type: Article

References (30)

1. L.M. Deshpande, T.R. Fritsche, G.J. Moet, and et al. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program Diagn Microbiol Infect Dis 58 2007 163 170
2. A.M. Ramsey, and M.D. Zilberberg Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006 Infect Control Hosp Epidemiol 30 2009 184 186
3. G. Ghanem, R. Hachem, Y. Jiang, and et al. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients Infect Control Hosp Epidemiol 28 2007 1054 1059
4. C.A. Diaz-Granados, and J.A. Jernigan Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection J Infect Dis 191 2005 588 595
5. M. Gearhart, J. Martin, S. Rudich, and et al. Consequences of vancomycin-resistant Enterococcus in liver transplant recipients: a matched control study Clin Transplant 19 2005 711 716
6. S. Kraft, E. Mackler, P. Schlickman, and et al. Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients Support Care Cancer 19 2011 1969 1974
7. D.W. Whang, L.G. Miller, N.M. Partain, and J.A. McKinnell Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal blood stream infections Antimicrob Agents Chemother 57 2013 5013 5018
8. T. Kelesidis, R. Humphries, D.Z. Uslan, and D.A. Pegues Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians Clin Infect Dis 52 2011 228 234
9. J.M. Munita, N.N. Mishra, D. Alvarez, and et al. Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible Enterococcus faecium harboring LiaSR substitutions Clin Infect Dis 59 2014 1277 1280
10. E.A. King, D. McCoy, S. Desai, and et al. Vancomycin-resistant Enterococcal bacteremia and daptomycin: are higher doses necessary? J Antimicrob Chemother 66 2011 2112 2118
11. G. Sakoulas, A.S. Bayer, J. Pogliano, and et al. Ampicillin enhances daptomycin- and cationic host defense peptide-mediate killing of ampicillin and vancomycin-resistant Enterococcus faecium Antimicrob Agents Chemother 56 2012 838 844
12. K.V. Rolston, J. Segreti, K.C. Lamp, and L.V. Friedrich Cubicin Outcomes Registry and Experience (CORE) methodology Am J Med 120 2007 S4 S5
13. X. Song, A. Srinivasan, D. Plaut, and T.M. Perl Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs Infect Control Hosp Epidemiol 24 2003 251 256
14. C.A. Diaz-Granados, S.M. Zimmer, M. Klein, and J.A. Jernigan Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis Clin Infect Dis 41 2005 327 333
15. National Center for Preparedness, Detection, and Control of Infectious Diseases (U.S.), Division of Healthcare Quality Promotion. The direct medical costs of healthcare-associated infections in U.S. hospitals and the benefits of prevention. http://stacks.cdc.gov/view/cdc/11550/. Accessed 23 August 2013.
16. E.N. Vergis, M.K. Hayden, J.W. Chow, and et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study Ann Intern Med 135 2001 484 492
17. K.M. Erlandson, J. Sun, P.C. Iwen, and M.E. Rupp Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia Clin Infect Dis 46 2008 30 36
18. C.A. Arias, G.A. Contreras, and B.E. Murray Management of multidrug-resistant enterococcal infections Clin Microbiol Infect 16 2010 555 562
19. R.M. Humphries, T. Kelesidis, R. Tewhey, and et al. Genotypic and phenotypic evaluation of the evolution of high-level daptomycin non-susceptibility in vancomycin-resistant Enterococcus faecium Antimicrob Agents Chemother 56 2012 6051 6053
20. J. Pogliano, N. Pogliano, and J.A. Silverman Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins J Bacteriol 194 2012 4494 4504
21. T.T. Tran, D. Panesso, N.N. Mishra, and et al. Daptomycin-resistant Enterococcus faecalis diverts the antibiotic molecule from the division septum and remodels cell membrane phospholipids MBio 4 4 2013 e00281-13
22. G. Sakoulas, W.E. Rose, P. Nonejuie, and et al. Ceftaroline restores daptomycin activity of daptomycin-resistant vancomycin-resistant Enterococcus faecium Antimicrob Agents Chemother 58 2014 1494 1500
23. J.M. Munita, D. Panesso, L. Diaz, and et al. Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints Antimicrob Agents Chemother 56 2012 4354 4359
24. S. Gardete, S.W. Wu, S. Gill, and A. Tomasz Role of vraRS in antibiotic resistance and antibiotic-induced stress response in Staphylococcus aureus Antimicrob Agents Chemother 50 2006 3424 3434
25. J.M. Munita, T.T. Tran, L. Diaz, and et al. A liaF codon deletion abolishes daptomycin bactericidal activity against vancomycin-resistant Enterococcus faecalis Antimicrob Agents Chemother 57 2013 2831 2833
26. C.A. Arias, H.A. Torres, K.V. Singh, and et al. Failure of daptomycin monotherapy for endocarditis caused by an Enterococcus faecium strain with vancomycin-resistant and vancomycin-susceptible subpopulations and evidence of in vivo loss of the vanA gene cluster Clin Infect Dis 45 2007 1343 1346
27. C.A. Arias, D. Panesso, D.M. McGrath, and et al. Genetic basis for in vivo daptomycin resistance in enterococci N Engl J Med 365 2011 892 900
28. J.M. Entenza, M. Giddey, J. Vouillamoz, and P. Moreillon In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin Int J Antimicrob Agents 35 2010 451 456
29. A. Berti, J. Wergin, G. Girdaukas, and et al. Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combination with other antibiotics Antimicrob Agents Chemother 56 2012 5046 5053
30. J.R. Smith, K.E. Barber, A. Raul, and et al. β-lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium J Antimicrob Chemother 2015 [Epub ahead of print]